Stephen Dilly News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting

Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesLauren mustoCarrie mckimMathew millerJohn maraganoreDerek gauntlettProducts servicesCompany enzyme catalyzed oligonucleotideCodexis incSecurities exchangeExchange commissionTechnology at codexisOptimization servicesAlnylam pharmaceuticalsCodexi centerPresents groundbreaking enzymatic synthesis data

Codexis (CDXS) Presents Enzymatic Synthesis Data

Codexis (CDXS) Presents Enzymatic Synthesis Data
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJohn maraganoreDerek gauntlettMathew millerCodexis incProducts servicesOptimization servicesAlnylam pharmaceuticalsTechnology at codexisCompany enzyme catalyzed oligonucleotideCodexi centerSpotlight presentationFormer chief executive officerCodexi strategic advisoryEnzyme catalyzed oligonucleotideStephen dilly

Codexis, Inc (NASDAQ:CDXS) Q4 2023 Earnings Call Transcript

Codexis, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.16.

Dan ariasKayla hostetlerCarrie mckimStefan lutzJohn maraganoreKevin norrettMasad damhaEvan stamplerJim lalondeBrandon couillardSynthesis innovation labCodexis incExchange commissionNestle health scienceAlnylam pharmaceuticalsInnovation lab

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesJim lalondeMasad damhaJohn maraganoreDavid butlerCarrie mckimLauren mustoHealth scienceInnovatus capital partnersAlnylam pharmaceuticalsExchange commissionJames mcgill professor at universitySecurities exchangeHongene biotech corporationCodexis incInnovation lab

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

28.02.2024 - Anticipate 2024 Product Revenue Growth of at Least 10% vs. 2023 Excluding Enzyme Sales Related to PAXLOVID Recently Announced Debt Financing Reinforces Strong Financial Position with Projected Runway Through Expected Positive Cash-flow Around End .

United statesJohn maraganoreDavid butlerLauren mustoCarrie mckimMasad damhaJim lalondeCodexis incSynthesis innovation labInnovatus capital partnersJames mcgill professor at universitySecurities exchangeExchange commissionHealth scienceAlnylam pharmaceuticalsHongene biotech corporation